I-Pirfenidone CAS 53179-13-8 Ubunyulu ≥99.0% IPF

Inkcazelo emfutshane:

Igama leKhemikhali: I-Pirfenidone

CAS: 53179-13-8

Ubunyulu: ≥99.0%

Imbonakalo: Umgubo weCrystalline oMhlophe ukuya kuMthubi

Umgangatho ophezulu, iMveliso yoRhwebo

Kunyango lwe-Idiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Nikeza ngokucoceka okuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: I-Pirfenidone
CAS: 53179-13-8

Iipropati zeMichiza:

Igama leMchiza I-Pirfenidone
Izithethantonye Perfenidone;I-5-Methyl-1-Phenylpyridine-2 (1H) -enye;PFD;S-7701;AMR-69
Inombolo yeCAS 53179-13-8
Inombolo yeCAT RF-API108
Ubume beStokhwe Ikhona evenkileni
Ifomula yeemolekyuli C12H11NO
Ubunzima beMolekyuli 185.22
Indawo yokunyibilika 96.0 ukuba 97.0℃
Ukunyibilika Inyibilika kwi-DMSO
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo weCrystalline oMhlophe ukuya koMthubi
Ukuchongwa IR
Ubunyulu ≥99.0%
Ilahleko ekomisweni ≤0.50%
Uthuthu lweSulfated ≤0.20%
Ukungacoceki Okukodwa ≤0.50%
Ukungcola ngokupheleleyo ≤1.0%
Iintsimbi ezinzima ≤20ppm
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa API, Idiopathic Pulmonary Fibrosis (IPF)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-Pirfenidone (CAS: 53179-13-8) ikwiqela lamayeza abizwa ngokuba yi-antifibrotic agents.I-Pirfenidone ibonise umsebenzi kwiimeko ezininzi ze-fibrotic, kubandakanywa nemiphunga, izintso kunye nesibindi.Ichaphazela amajoni omzimba wakho kwaye inciphisa inani le-fibrosis (i-scarring) emiphungeni.I-Pirfenidone lelinye lamayeza amabini avunyiweyo eCanada ukunyanga i-Idiopathic Pulmonary Fibrosis (IPF).I-Pirfenidone iyi-inhibitor yokuvelisa i-TGF-β kunye ne-TGF-β evuselela ukuveliswa kwe-collagen, iyanciphisa ukuveliswa kwe-TNF-α kunye ne-IL-1β, kwaye iphinde ibe ne-anti-fibrotic kunye ne-anti-inflammatory properties.Yavunywa okokuqala eJapan kunyango lwezigulane ezine-idiopathic pulmonary fibrosis emva kwezilingo zeklinikhi, phantsi kwegama lezorhwebo likaPirespa nguShionogi, kwi-2008. Yavunywa ukuba isetyenziswe kwi-European Union kwi-2011, eCanada kwi-2012, nakwi-2012. eUnited States ngo-Oktobha 2014.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi